Table 5

Adjusted analysis of HRs (95% CLs) of deaths from colorectal cancer by time from diagnosis (days) to commencement of specified treatment: South Australians major public hospitals, diagnoses 2000–2010*

TreatmentTimeFollow-up time from diagnoses
≤2 years3–10 years
Number of casesHR (95% CL)sNumber of casesHR (95% CL)s
Surgical treatment
(surgery cases)
<309881.007141.00
31–603550.57 (0.40 to 0.82)3020.92 (0.62 to 1.36)
61–901000.59 (0.35 to 1.02)761.13 (0.60 to 2.10)
>902320.59 (0.41 to 0.84)1861.24 (0.85 to 1.83)
Radiotherapy
(radiotherapy cases)
<301291.00871.00
31–602330.85 (0.54 to 1.32)1731.00 (0.59 to 1.72)
61–901070.44 (0.23 to 0.84)891.26 (0.70 to 2.27)
>901470.62 (0.40 to 0.98)891.60 (0.90 to 2.85)
Chemotherapy
(chemotherapy cases)
<302381.001201.00
31–606330.71 (0.55 to 0.92)4590.98 (0.66 to 1.47)
61–903820.51 (0.38 to 0.70)2891.01 (0.65 to 1.55)
>903030.40 (0.30 to 0.55)2331.04 (0.68 to 1.59)
Any treatment
(surgery cases)
<3010301.007441.00
31–604280.59 (0.43 to 0.81)3610.94 (0.66 to 1.33)
61–901180.48 (0.43 to 0.81)951.11 (0.66 to 1.89)
>90990.62 (0.37 to 1.02)781.83 (1.12 to 2.98)
  • *Four Cox proportional hazards regression analyses (one per treatment category), adjusting for age, sex, socioeconomic status, service accessibility, local health network, subsite, stage, grade and diagnostic period (tables 2 and 3); date of censoring of live cases: 31 December 2012.

  • CL, confidence limit.